International Aids Vaccine Initiative

This is an early-stage study to test the safety and immune response of a new HIV vaccine candidate. It will enroll 120 healthy adults in Southern Africa, including people living with HIV who have their virus well-controlled with medication. The main goal is to see if the vaccine …

This study is testing a new tuberculosis (TB) vaccine called MTBVAC to see if it can prevent people from getting TB disease. It will involve 5,500 healthy teenagers and adults, aged 14-45, who live in a region where TB is common. Participants will receive either the vaccine or a …

This is an early-stage study testing three different experimental mRNA vaccines designed to prevent HIV infection. It will enroll 96 healthy, HIV-negative adults in South Africa to check if the vaccines are safe and if they trigger a helpful immune response. The study will test t…